According to Theravance Biopharma
's latest financial reports the company has $0.21 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.21 B | -51.79% |
2022-12-31 | $0.44 B | -230.49% |
2021-12-31 | $-0.34 B | 11.46% |
2020-12-31 | $-0.31 B | 35.7% |
2019-12-31 | $-0.23 B | 333.89% |
2018-12-31 | $-51.59 M | -144.79% |
2017-12-31 | $0.11 B | -67.11% |
2016-12-31 | $0.35 B | 44.09% |
2015-12-31 | $0.24 B | -16.12% |
2014-12-31 | $0.28 B | -1801.13% |
2013-12-31 | $-17.04 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Corcept Therapeutics
CORT | $0.50 B | 137.90% | ๐บ๐ธ USA |
Collegium Pharmaceutical
COLL | $0.19 B | -8.25% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $0.38 B | 82.11% | ๐บ๐ธ USA |
Catalent CTLT | $3.68 B | 1,631.03% | ๐บ๐ธ USA |